L. M. Marcho

Potent Estrogen Receptor β Agonists with Inhibitory Activity In Vitro, Fail to Suppress Xenografts of Endocrine-Resistant Cyclin-dependent Kinase 4/6 inhibitor-Resistant Breast Cancer Cells

The paper tests the in vivo efficacy of estrogen receptor β agonists combined with tamoxifen in endocrine-resistant breast cancer models, finding no tumor volume reduction despite in vitro success.

Molecular signature of RV cardiac remodeling associated with Polymerase Gamma mutation

This study characterizes cardiac remodeling in POLG mutant mice, identifying sex-specific differences and RNA-seq-driven insights into inflammation, fibrosis, and heart failure pathways.